Liver Diseases
Welcome,         Profile    Billing    Logout  
 306 Companies   474 Products   474 Products   223 Mechanisms of Action   25 Trials   4911 News 


«12...89101112131415161718...9899»
  • ||||||||||  Inlyta (axitinib) / Pfizer
    Enrollment closed, Trial primary completion date, Metastases:  Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma (clinicaltrials.gov) -  Jul 23, 2016   
    P2,  N=45, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Jul 2016
  • ||||||||||  Increlex (mecasermin) / Ipsen
    Enrollment change, Trial withdrawal, Trial primary completion date:  Increlex Treatment of Children With Chronic Liver Disease and Short Stature (clinicaltrials.gov) -  Jul 15, 2016   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: May 2016 --> May 2017 N=20 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2013 --> Oct 2011
  • ||||||||||  Phase classification, Enrollment change, Trial termination, Trial primary completion date:  Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability (clinicaltrials.gov) -  Jul 13, 2016   
    P=N/A,  N=103, Terminated, 
    Active, not recruiting --> Completed Phase classification: P2 --> P=N/A | N=20 --> 103 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2016 --> Dec 2012; Funding exhausted.
  • ||||||||||  sorafenib / Generic mfg.
    Enrollment change, Trial primary completion date:  Sorafenib for Hepatopulmonary Syndrome (clinicaltrials.gov) -  Jul 7, 2016   
    P2,  N=30, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Jul 2016 N=50 --> 30 | Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  Xalkori (crizotinib) / Pfizer
    Trial completion, Enrollment change, Metastases:  Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients (clinicaltrials.gov) -  Jul 7, 2016   
    P1,  N=88, Completed, 
    N=50 --> 30 | Trial primary completion date: Jun 2016 --> Jun 2017 Active, not recruiting --> Completed | N=70 --> 88
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Hepatitis A Vaccination in the Elderly (clinicaltrials.gov) -  Jun 29, 2016   
    P=N/A,  N=60, Completed, 
    Initiation date: Aug 2014 --> Aug 2015 | Trial primary completion date: Aug 2015 --> Sep 2016 Recruiting --> Completed | N=120 --> 60 | Trial primary completion date: Nov 2011 --> Jul 2015
  • ||||||||||  pravastatin / Generic mfg., sorafenib / Generic mfg.
    Enrollment closed, Trial primary completion date:  PRODIGE 21t: Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis (clinicaltrials.gov) -  Jun 24, 2016   
    P2,  N=160, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Dec 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2016
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies (clinicaltrials.gov) -  Jun 24, 2016   
    P=N/A,  N=13, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2016 Recruiting --> Active, not recruiting | N=60 --> 13 | Trial primary completion date: Sep 2014 --> Jul 2016
  • ||||||||||  MRX34 / Synlogic
    Trial primary completion date:  A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection (clinicaltrials.gov) -  Jun 23, 2016   
    P1,  N=200, Recruiting, 
    Recruiting --> Active, not recruiting | N=60 --> 13 | Trial primary completion date: Sep 2014 --> Jul 2016 Trial primary completion date: Dec 2016 --> Mar 2017
  • ||||||||||  Trial primary completion date:  Gilead Sustained Virologic Response (SVR) Registry (clinicaltrials.gov) -  Jun 23, 2016   
    P=N/A,  N=7000, Enrolling by invitation, 
    Trial primary completion date: Jul 2019 --> Oct 2020 Trial primary completion date: Jul 2019 --> Oct 2020
  • ||||||||||  Enrollment closed, Trial primary completion date, Adherence:  Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection (clinicaltrials.gov) -  Jun 17, 2016   
    P=N/A,  N=85, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jan 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Trial completion:  TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) (clinicaltrials.gov) -  Jun 17, 2016   
    P1,  N=40, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016 Enrolling by invitation --> Completed
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  Resveratrol and Human Hepatocyte Function in Cancer (clinicaltrials.gov) -  Jun 15, 2016   
    P1/2,  N=0, Withdrawn, 
    Recruiting --> Completed | N=150 --> 71 | Trial primary completion date: Dec 2015 --> May 2016 N=80 --> 0 | Initiation date: Dec 2016 --> Dec 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2017 --> Jun 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  HEofT&O: Hemodynamic Effects of Terlipressin and High Dose Octreotide (clinicaltrials.gov) -  Jun 10, 2016   
    P4,  N=88, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=240 --> 88 | Trial primary completion date: Feb 2015 --> Jun 2016
  • ||||||||||  Trial completion, Trial primary completion date, Gold standard:  Renal Function Determination in Patients With Liver Cirrhosis (clinicaltrials.gov) -  Jun 10, 2016   
    P=N/A,  N=92, Completed, 
    Recruiting --> Completed | N=240 --> 88 | Trial primary completion date: Feb 2015 --> Jun 2016 Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015
  • ||||||||||  Trial completion, Enrollment change:  Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy (clinicaltrials.gov) -  Jun 10, 2016   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015 Active, not recruiting --> Completed | N=60 --> 30